The Latest Breaking News from Novo Nordisk

Thousands are expected to be offered the appetite suppressant Wegovy on prescription

Thousands of people expected to be offered the appetite suppressant popular with celebrities on prescription

The French drug safety agency on Wednesday announced it was stepping up monitoring of Ozempic, a diabetes drug promoted by influencers on social networks who flaunt its weight-loss properties. As well as health concerns, the authorities say the increased demand could jeopardise access for legitimate diabetic patients.

Ozempic has been catapulted into the public eye in recent months as celebrities and wellness influencers started taking it for weight loss. But Ozempic is a diabetes drug — and the craze has led to a shortage, leaving those who need it for Type 2 diabetes at a loss.

Paris (AFP) - The diabetes drug Ozempic has become a social media phenomenon for its weight loss properties, but its soaring popularity has led to global shortages and doctors warn about the potential side effects. 

Growth stock Novo Nordisk is showing strength after FDA approval of breakthrough oral drug for type 2 diabetes. Shares are in a base.

Under NICE guidelines, Ozempic can only be prescribed to people with Type 2 diabetes who meet certain criteria, such as having a BMI of 30 or more. But the Sunday Mirror discovered the drug can easily be bought online and in beauty salons by people without diabetes.

The 'skinny jab' is usually used as a diabetes drug for weight loss and can be bought online without an NHS prescription but charities are warning it is a loaded gun

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy